← Back to grants
Grant✓ Small businesses may apply

Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)

National Institutes of Health

Opportunity #
PAR-25-369
Agency
National Institutes of Health
ALN (CFDA)
93.313, 93.279, 93.310, 93.399, 93.172, 93.865, 93.867, 93.855, 93.173, 93.121, 93.113, 93.242, 93.989, 93.853
Status
posted
Posted
Jan 13, 2025
Closes
Nov 18, 2026
Funding instrument
Grant
Category
Education, Environment, Health, Income Security and Social Services
Cost sharing required
No

Who can apply

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Synopsis

The purpose of this NOFO is to invite Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods. Approaches may include but are not limited to empirical qualitative and quantitative methods, as well as conceptual, legal, and normative analyses. Direct involvement of key stakeholders where appropriate is encouraged. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information. 

Contact

National Institutes of Health · grantsinfo@nih.gov

View full notice on Grants.gov ↗